Product Information

MEDROXYPROGESTERONE 150 MG/ML is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $26.4789 per ML under NDC 70121148001. Its NADAC has been published 163 times since Oct 11, 2023.

FDA first approved this application on Jun 7, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MEDROXYPROGESTERONE 150 MG/ML

medroxyprogesterone acetate
$26.4789per ML

Strength

150 mg/mL

NDC

70121148001

Classification

Generic

Dosage Form

INJECTION, SUSPENSION

Route

INTRAMUSCULAR

Effective Date

11/18/2026

Active Ingredients

MEDROXYPROGESTERONE ACETATE

Approval Type

Generic (ANDA)

FDA Application

ANDA215397

FDA Approved

6/7/2023

TE Code

AB

On Market Since

6/13/2023

Pharmacological Classes

Progesterone Congeners
Progestin

Price Statistics

The NADAC for MEDROXYPROGESTERONE 150 MG/ML has been published 163 times since Oct 11, 2023, and over the history we have for it it has declined 36.7%. The table below summarizes its recorded NADAC range and movement.

Current price$26.4789 per ML
All-time high$43.5023 (Nov 15, 2023)
All-time low$25.6030 (May 20, 2026)
52-week high$31.4564
52-week low$25.6030
Median price$32.9390
Average price$33.6284
Largest weekly change+39.7% (Aug 21, 2024)
Weeks tracked163
Tracking sinceOct 11, 2023

Price History

1W

-1.6%

1M

-3.2%

3M

-7.1%

6M

+3.4%

1Y

-15.8%

3Y

-39.1%

5Y

N/A

All

-36.7%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 35% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MEDROXYPROGESTERONE 150 MG/ML?

The current National Average Drug Acquisition Cost (NADAC) for MEDROXYPROGESTERONE 150 MG/ML, manufactured by Amneal Pharmaceuticals LLC, is $26.4789 per ML (NDC 70121148001), effective Nov 18, 2026.

How has the price of MEDROXYPROGESTERONE 150 MG/ML changed over time?

Over the history we have for it, the NADAC for MEDROXYPROGESTERONE 150 MG/ML has declined 36.7%. It has been tracked across 163 weekly CMS publications since Oct 11, 2023.

What are the highest and lowest recorded NADAC prices for MEDROXYPROGESTERONE 150 MG/ML?

Since Oct 11, 2023, the NADAC for MEDROXYPROGESTERONE 150 MG/ML has ranged from a low of $25.6030 (May 20, 2026) to a high of $43.5023 (Nov 15, 2023), with a median of $32.9390 per ML.

Are there cheaper alternatives to MEDROXYPROGESTERONE 150 MG/ML?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MEDROXYPROGESTERONE 150 MG/ML, is $17.0951 per ML — about 35% below MEDROXYPROGESTERONE 150 MG/ML.

Who manufactures MEDROXYPROGESTERONE 150 MG/ML?

MEDROXYPROGESTERONE 150 MG/ML (NDC 70121148001) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.